NEXUS GLOBAL GROUP SCIENCES
LIVE

Serial Number

99638535

Owner

Vaniam Group LLC

Attorney

Matthew J. Gryzlo

Filing Date

Feb 6, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NEXUS GLOBAL GROUP SCIENCES Trademark

Serial Number: 99638535

NEXUS GLOBAL GROUP SCIENCES is a trademark filed by Vaniam Group LLC on February 6, 2026. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Vaniam Group LLC (11 trademarks)

1444 N. Orleans St., Suite 8K
Chicago, IL 60610

Entity Type: 16

Trademark Details

Filing Date

February 6, 2026

Registration Date

Not Registered

Goods & Services

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Technical consulting in the field of pharmaceutical studies; Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the field of pharmaceutical research and development; Development of digital codes, digital platforms and digital programs for others for therapeutic areas; Software development and product development consulting in the field of healthcare

Business strategy development services; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Business consultation and management regarding marketing activities and launching of new products; Providing classes, seminars, workshops, presentations and retreats in the field of pharmaceutical development; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Consulting services in the field of medical product approval for commercial purposes; Marketing consulting; Marketing advisory services; Digital marketing services; Creative marketing plan development services; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Market research and market intelligence services; Competitive intelligence services; Providing publication plans for others to share clinical trial results, scientific research, and therapeutic innovations in peer-reviewed journals or conferences; Developing abstracts for clients relaying medical and scientific information at congresses; Advising on the design and presentation of posters and oral sessions as medical and scientific congresses; Creating foundational scientific documents used to support publication efforts relating to pharmaceuticals; Consulting and/or co-creating manuscripts submitted to medical journals, including facilitation of peer review processes and ensuring compliance with publication standards

Clinical medical consultation services

Arranging and conducting of conferences and symposia in the field of medical science; Consultancy relating to arranging and conducting of congresses; Consultancy relating to arranging and conducting of conferences; Arranging, conducting and organization of seminars, lecture presentations and symposiums for internal training; Arranging and conducting of seminars and workshops in the field of pharmaceutical research; Arranging and conducting of training seminars in the field of pharmaceutical research

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 3, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 6, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2026 NWOS
NEW APPLICATION ENTERED
Feb 6, 2026 NWAP